Search Results - "SOENO, CHIE"

Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer by Sugano, Teppei, Seike, Masahiro, Noro, Rintaro, Soeno, Chie, Chiba, Mika, Zou, Fenfei, Nakamichi, Shinji, Nishijima, Nobuhiko, Matsumoto, Masaru, Miyanaga, Akihiko, Kubota, Kaoru, Gemma, Akihiko

“…Patients with non-small cell lung cancer (NSCLC) EGFR mutations have shown a dramatic response to EGFR inhibitors (EGFR-TKI). EGFR T790M mutation and MET…”
Get full text

miR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma by YAMAMOTO, KAZUO, SEIKE, MASAHIRO, TAKEUCHI, SUSUMU, SOENO, CHIE, MIYANAGA, AKIHIKO, NORO, RINTARO, MINEGISHI, YUJI, KUBOTA, KAORU, GEMMA, AKIHIKO

“…Malignant pleural mesothelioma (MPM) is a rapidly fatal malignancy that is increasing in incidence in Japan. In this study, we performed gene and microRNA…”
Get full text

Histone deacetylase inhibitor enhances sensitivity of non‐small‐cell lung cancer cells to 5‐FU/S‐1 via down‐regulation of thymidylate synthase expression and up‐regulation of p21waf1/cip1 expression by Noro, Rintaro, Miyanaga, Akihiko, Minegishi, Yuji, Okano, Tetsuya, Seike, Masahiro, Soeno, Chie, Kataoka, Kiyoko, Matsuda, Kuniko, Yoshimura, Akinobu, Gemma, Akihiko

“…It is desirable to find more appropriate therapeutic opportunities in non‐small‐cell lung cancer (NSCLC) due to the current poor prognosis of affected…”
Get full text

Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexed by TAKEUCHI, SUSUMU, SEIKE, MASAHIRO, NORO, RINTARO, SOENO, CHIE, SUGANO, TEPPEI, ZOU, FENFEI, UESAKA, HARUKA, NISHIJIMA, NOBUHIKO, MATSUMOTO, MASARU, MINEGISHI, YUJI, KUBOTA, KAORU, GEMMA, AKIHIKO

“…Pemetrexed (PEM) is currently recommended as one of the standard anticancer drugs for malignant pleural mesothelioma (MPM). However, the mechanism of the…”
Get full text

Histone deacetylase inhibitor enhances sensitivity of non‐small‐cell lung cancer cells to 5‐FU/S‐1 via down‐regulation of thymidylate synthase expression and up‐regulation of p21 waf1/cip1 expression by Noro, Rintaro, Miyanaga, Akihiko, Minegishi, Yuji, Okano, Tetsuya, Seike, Masahiro, Soeno, Chie, Kataoka, Kiyoko, Matsuda, Kuniko, Yoshimura, Akinobu, Gemma, Akihiko

“…It is desirable to find more appropriate therapeutic opportunities in non‐small‐cell lung cancer (NSCLC) due to the current poor prognosis of affected…”
Get full text

The Anticancer Effect of Histone Deacetylase Inhibitors and Combination with the Cytotoxic Agents in Lung Cancer Cells: Biological Analyses for Future Clinical Application by Noro, Rintaro, Miyanaga, Akihiko, Shimokawa, Tsuneo, Kuribayashi, Hidehiko, Mizutani, Hideaki, Minegishi, Yuji, Okano, Tetsuya, Seike, Masahiro, Soeno, Chie, Kataoka, Kiyoko, Matsuda, Kuniko, Yoshimura, Akinobu, Gemma, Akihiko

Get full text

MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells by CAO, MENGRU, SEIKE, MASAHIRO, SOENO, CHIE, MIZUTANI, HIDEAKI, KITAMURA, KAZUHIRO, MINEGISHI, YUJI, NORO, RINTARO, YOSHIMURA, AKINOBU, CAI, LI, GEMMA, AKIHIKO

“…Transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition (EMT) has been shown to be related to the pathogenesis of various diseases…”
Get full text

miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells by NISHIJIMA, NOBUHIKO, SEIKE, MASAHIRO, SOENO, CHIE, CHIBA, MIKA, MIYANAGA, AKIHIKO, NORO, RINTARO, SUGANO, TEPPEI, MATSUMOTO, MASARU, KUBOTA, KAORU, GEMMA, AKIHIKO

“…Nintedanib (BIBF1120) is a multi-targeted angiokinase inhibitor and has been evaluated in idiopathic pulmonary fibrosis and advanced non-small cell lung cancer…”
Get full text

Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling by OKANO, TETSUYA, SEIKE, MASAHIRO, KURIBAYASHI, HIDEHIKO, SOENO, CHIE, ISHII, TAKEO, KIDA, KOZUI, GEMMA, AKIHIKO

“…To date, a number of potential biomarkers for lung squamous cell cancer (SCC) have been identified; however, sensitive biomarkers are currently lacking to…”
Get full text

MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation by Noro, Rintaro, Seike, Masahiro, Zou, Fenfei, Soeno, Chie, Matsuda, Kuniko, Sugano, Teppei, Nishijima, Nobuhiko, Matsumoto, Masaru, Kitamura, Kazuhiro, Kosaihira, Seiji, Minegishi, Yuji, Yoshimura, Akinobu, Kubota, Kaoru, Gemma, Akihiko

“…Lung adenocarcinoma patients with EGFR gene mutations have shown a dramatic response to gefitinib. However, drug resistance eventually emerges which limits the…”
Get full text

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer by Matsumoto, Masaru, Seike, Masahiro, Noro, Rintaro, Soeno, Chie, Sugano, Teppei, Takeuchi, Susumu, Miyanaga, Akihiko, Kitamura, Kazuhiro, Kubota, Kaoru, Gemma, Akihiko

“…Mammalian target of rapamycin (mTOR) inhibitors have anti-tumor effects against renal cell carcinoma, pancreatic neuroendocrine cancer and breast cancer. In…”
Get full text

(2)The Anticancer Effect of Histone Deacetylase Inhibitors and Combination with the Cytotoxic Agents in Lung Cancer Cells: Biological Analyses for Future Clinical Application by Rintaro Noro, Akihiko Miyanaga, Tsuneo Shimokawa, Hidehiko Kuribayashi, Hideaki Mizutani, Yuji Minegishi, Tetsuya Okano, Masahiro Seike, Chie Soeno, Kiyoko Kataoka, Kuniko Matsuda, Akinobu Yoshimura, Akihiko Gemma

“…「Introduction」 Even though a wide range of anticancer agents have been developed, many patients with advanced solid tumors still have a poor prognosis. For the…”
Get full text

Abstract 756: Inhibition of ABCB1 overcomes cancer stem cell-like properties and acquired resistance to MET inhibitor in non-small cell lung cancer by Sugano, Teppei, Seike, Masahiro, Noro, Rintaro, Soeno, Chie, Nakamichi, Shinji, Nishijima, Nobuhiko, Matsumoto, Masaru, Takeuchi, Susumu, Miyanaga, Akihiko, Kubota, Kaoru, Gemma, Akihiko

“…Non-small cell lung cancer (NSCLC) patients with EGFR mutations have shown a dramatic response to EGFR inhibitors (EGFR-TKI). EGFR T790M mutation and MET…”
Get full text

Abstract 3541: Significance of osteopontin in the sensitivity of malignant pleural mesothelioma cells to pemetrexed by Seike, Masahiro, Takeuchi, Susumu, Soeno, Chie, Noro, Rintaro, Minegishi, Yuji, Gemma, Akihiko

“…Introduction: Malignant pleural mesothelioma (MPM) is one of the fatal cancers associated with asbestos exposure.Pemetrexed (PEM) is currently recommended as…”
Get full text

Abstract 784: Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexed by Takeuchi, Susumu, Seike, Masahiro, Noro, Rintaro, Soeno, Chie, Sugano, Teppei, Zou, Fenfei, Matsumoto, Masaru, Miyanaga, Akihiko, Minegishi, Yuji, Kubota, Kaoru, Gemma, Akihiko

“…Background: Pemetrexed (PEM) is currently recommended as one of the standard anticancer drugs for malignant pleural mesothelioma (MPM). However, the mechanism…”
Get full text

Abstract 2298: MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in pulmonary epithelium cells by Seike, Masahiro, Mengru, Cao, Soeno, Chie, Noro, Rintaro, Minegishi, Yuji, Yoshimura, Akinobu, Gemma, Akihiko

“…Transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition (EMT) has been reported to be related to pathogenesis of various diseases…”
Get full text

Abstract 5548: High copy number of the MET gene predicts resistance to EGFR-TKI in non-small cell lung cancer patients by Noro, Rintaro, Seike, Masahiro, Soeno, Chie, Matsuda, Kuniko, Sugano, Teppei, Nishijima, Nobuhiko, Toyokawa, Masaru, Kitamura, Kazuhiro, Kosaihira, Seiji, Minegishi, Yuji, Yoshimura, Akinobu, Kubota, Kaoru, Gemma, Akihiko

“…Background Non-small cell lung cancer (NSCLC) patients with EGFR gene mutations have shown a dramatic responses to EGFR tyrosine kinase inhibitor (EGFR-TKI)…”
Get full text

HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner by MIZUTANI, HIDEAKI, OKANO, TETSUYA, MINEGISHI, YUJI, MATSUDA, KUNIKO, SUDOH, JUNKO, KITAMURA, KAZUHIRO, NORO, RINTARO, SOENO, CHIE, YOSHIMURA, AKINOBU, SEIKE, MASAHIRO, GEMMA, AKIHIKO

“…Epithelial to mesenchymal transition (EMT) is induced by transforming growth factor-β1 (TGF-β1) and is a crucial event for cancer cells to acquire invasive and…”
Get full text

Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expression by Noro, Rintaro, Miyanaga, Akihiko, Minegishi, Yuji, Okano, Tetsuya, Seike, Masahiro, Soeno, Chie, Kataoka, Kiyoko, Matsuda, Kuniko, Yoshimura, Akinobu, Gemma, Akihiko

“…It is desirable to find more appropriate therapeutic opportunities in non-small-cell lung cancer (NSCLC) due to the current poor prognosis of affected…”
Get full text